Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Low-dose transdermal testosterone tested in chronic stable angina

Aug. 30, 2000

Results of dosing studies on tezosentan in CHF reported

Aug. 29, 2000

Mast cell tryptase explored as a marker in stable CAD

Aug. 29, 2000

V1A/V2 receptor antagonist conivaptan in the news

Aug. 29, 2000

Hormone replacement therapy shows no cardiovascular benefits in older women

Aug. 29, 2000

Orally bioavailable potassium (IKs) blockers synthesized by Bristol-Myers Squibb

Aug. 29, 2000

Ceramide-coated catheters significantly reduce restenosis in vivo

Aug. 29, 2000

Chymase inhibition -- a route to cardiovascular drug discovery

Aug. 28, 2000

Individuals with manic depression may have lower heart attack risks

Aug. 28, 2000

Spironolactone improves survival in CHF, possibly by limiting cardiac fibrosis

Aug. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...